


The FamilieSCN2A Research Roundtable: A Family Perspective

Promising Initial Relutrigine (Prax-562) Clinical Data

Positive Step Towards a Treatment for SCN2A Gain-of-Function Patients

Building Towards A Cure: 2022

Not So Happy Holidays

Industry Relations Updates

It Takes a Village

Expanded Access Programs, What you Need to Know

